| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -9.5% | +18.6% |
| Cost of Revenue | $228K | +30.2% | +26.1% |
| Gross Profit | $906K | -16.0% | +16.8% |
| R&D Expense | $2K | +0.0% | -50.0% |
| SG&A Expense | $785K | -8.9% | +6.7% |
| Pre-tax Income | $64K | -67.3% | +327.0% |
| Net Income | $64K | -67.3% | +327.0% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | -16.6% | +47.2% |
| Accounts Receivable | $241K | +61.4% | -27.7% |
| Inventory | $77K | -23.6% | +121.7% |
| Current Assets | $1.5M | -10.6% | +25.7% |
| Total Assets | $1.5M | -10.1% | +23.3% |
| Total Liabilities | $1.6M | -12.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$56K | -137.9% | — |
| Investing Cash Flow | -$9K | -434.2% | — |
| +7.2% |
| Stockholders' Equity | -$98K | +39.4% | +64.9% |